Medspa Valuation 2026: What's Your Practice Worth?

Most medspa owners can tell you last month's revenue down to the dollar — but have no idea what their practice is actually worth. In a year when buyers are more active than they've been in a decade, that's a blind spot worth closing.

The medical aesthetics industry is in the middle of a consolidation wave. More than 90% of medspas are still independently owned, private-equity-backed platforms are expected to push 2026 toward record deal volume, and durable consumer demand keeps drawing outside capital into the space. Whether or not you ever plan to sell, that environment makes one question worth answering: what is your medspa actually worth, and what would move that number?

Here's the reframe that matters. Your valuation isn't just a sale price — it's the clearest scorecard you have for how healthy, profitable, and transferable your business really is. The same things that raise your multiple also make your practice easier to run, less dependent on you, and more resilient. So it's worth understanding even if a sale is years away, or never happens at all.

How Medspas Are Valued in 2026

Most medspas are valued on a multiple of EBITDA — earnings before interest, taxes, depreciation, and amortization. In plain terms, EBITDA is your real operating profit once you strip out financing and accounting noise. Buyers then 'normalize' that number by adding back owner perks and one-time costs that wouldn't continue under new ownership — an above-market owner salary, a personal vehicle, a one-off legal bill. That adjusted figure, not your top-line revenue, is what gets multiplied.

Current 2026 ranges look roughly like this:

• Small, single-location practices: about 3x–6x adjusted EBITDA, with higher operational risk pulling the number down.

• Standalone medspas more broadly: typically 4x–7x EBITDA.

• Multi-location platforms: around 6x–9x EBITDA.

• Scaled operators with strong recurring membership revenue and a real management team: can approach 10x–12x.

To make it concrete: a practice with $500,000 in normalized EBITDA might sell for roughly $2M–$3.5M, while $1M in EBITDA puts you in the $4M–$7M range. Two medspas with identical revenue can land millions of dollars apart — and the difference is almost always in the drivers below.

What Drives Your Multiple Up — or Down

Buyers aren't just paying for profit; they're paying for predictable profit that survives the sale. The factors that move your multiple the most:

• Owner and provider dependence. The single biggest lever at most practice sizes. If you personally perform a majority of treatments, much of the revenue walks out the door with you — and buyers discount accordingly.

• Recurring revenue. Membership and package revenue a buyer can count on earns a premium. Practices with roughly 30%+ of revenue from memberships are meaningfully more valuable than identical practices without one.

• Retention. A patient retention rate above ~60% signals durable demand rather than a constant, expensive scramble for new faces.

• Provider bench and tenure. A team of tenured injectors who'll stay on post-sale de-risks the whole deal.

• Clean financials. Accrual-based books, clear add-backs, and reliable reporting let a buyer trust your numbers — and trust raises offers.

• A diversified, modern service mix. Spreading revenue across treatments (and adopting genuinely useful technology) reduces reliance on any single service or trend.

The Owner-Dependence Trap

It's worth dwelling on that first item, because it's where most independent owners quietly cap their own value. The rough hierarchy buyers use:

• Owner performs 60%+ of treatments: the business essentially is the owner. Expect the low end of the range — often 3.5x–5x.

• Owner performs 20–40%: revenue is partly de-risked. This is the baseline for mid-range multiples.

• Owner is primarily a manager, not a main producer: the business runs without you day to day. This is where premium multiples live.

The fix isn't fast, but it is straightforward: build a provider bench, document your processes so they don't live only in your head, and gradually shift yourself from the treatment chair to the operator's seat. These are the same systems that make a medspa genuinely scalable — and the work pays off in your daily life long before it pays off at a closing table.

Building Value Before You Ever Sell

You don't raise a multiple in the month before a sale; you build it over years. The moves that matter most in 2026:

• Launch or strengthen a membership program. Recurring revenue is the most reliable valuation upgrade available to most owners — and it smooths cash flow in slow months.

• Reduce your concentration risk. Cross-train providers, spread your top patients across the team, and make sure no single injector — including you — controls the majority of revenue.

• Clean up the books now. Separate personal expenses, move to accrual accounting, and track EBITDA monthly so your add-backs are obvious and defensible.

• Document your systems. Written SOPs for consultations, follow-up, and clinical protocols turn tribal knowledge into a transferable asset.

• Think like a platform. If growth is the goal, a second well-run location can move you into a higher multiple tier — but only if the first one already runs without you. (More on that in knowing when you're truly ready to scale.)

The Bottom Line

Valuation is the ultimate report card for your medspa. A high multiple isn't luck — it's the byproduct of recurring revenue, a strong team, clean numbers, and a business that doesn't depend on you being in the building. Build those now and you win either way: a more valuable asset if you sell, and a calmer, more profitable practice if you don't.

One caveat worth stating plainly: this is educational, not a valuation or financial recommendation. The ranges here are market generalizations, and your real number depends on your specific financials and local market. Before making any decision based on value, get a formal valuation from a qualified M&A advisor or CPA who knows the aesthetics space.

Want help building the kind of practice buyers compete for — whether or not you ever plan to sell? That's exactly what we do at The Business of Aesthetics. Reach out, and let's talk about your next move.